Price $3.78 |
Market Cap
171.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
134.7
|
P/B
2.58
|
P/S
1.49
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.8K
|
FCF
-0.1
|
|
Op. Margin
-0.10%
|
Net Margin
1.10%
|
ROE
2.10%
|
ROI
-43.20%
|
|
ROA
1.10%
|
EPS Growth
104.10%
|
Current Ratio
2.1
|
Debt/Equity
7.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| La Jolla Pharmaceutical Compan (LJPC) | $3.96 | - | - | 109.7M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.62 | - | - | 78.9M | Strong Buy |
| Pieris Pharmaceuticals Inc (PIRS) | $4.51 | - | - | 344.9M | Strong Buy |
| Lannett Company, Inc. (LCI) | $2.53 | - | - | 126.8M | Strong Buy |
| Capital Senior Living Corporat (CSU) | $30.91 | - | - | 77.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
